vs
Side-by-side financial comparison of AVANOS MEDICAL, INC. (AVNS) and IREN Ltd (IREN). Click either name above to swap in a different company.
IREN Ltd is the larger business by last-quarter revenue ($184.7M vs $180.9M, roughly 1.0× AVANOS MEDICAL, INC.). AVANOS MEDICAL, INC. runs the higher net margin — -0.7% vs -84.1%, a 83.4% gap on every dollar of revenue. On growth, IREN Ltd posted the faster year-over-year revenue change (59.0% vs 0.7%). AVANOS MEDICAL, INC. produced more free cash flow last quarter ($21.3M vs $-468.0M).
Avanos Medical, Inc. is a medical technology company making clinical medical devices. The company consists of two franchises – Pain Management and Chronic Care – that address reducing the use of opioids while helping patients recover faster and preventing infection.
IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada.
AVNS vs IREN — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $180.9M | $184.7M |
| Net Profit | $-1.3M | $-155.4M |
| Gross Margin | 47.5% | 64.4% |
| Operating Margin | 1.4% | -63.0% |
| Net Margin | -0.7% | -84.1% |
| Revenue YoY | 0.7% | 59.0% |
| Net Profit YoY | 99.7% | -610.0% |
| EPS (diluted) | $-0.02 | $-0.52 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $180.9M | $184.7M | ||
| Q3 25 | $177.8M | $240.3M | ||
| Q2 25 | $175.0M | — | ||
| Q1 25 | $167.5M | — | ||
| Q4 24 | $179.6M | $116.1M | ||
| Q3 24 | $170.4M | $52.8M | ||
| Q2 24 | $171.7M | — | ||
| Q1 24 | $166.1M | $54.3M |
| Q4 25 | $-1.3M | $-155.4M | ||
| Q3 25 | $-1.4M | $384.6M | ||
| Q2 25 | $-76.8M | — | ||
| Q1 25 | $6.6M | — | ||
| Q4 24 | $-397.3M | $-21.9M | ||
| Q3 24 | $4.3M | $-51.7M | ||
| Q2 24 | $1.8M | — | ||
| Q1 24 | $-900.0K | $8.6M |
| Q4 25 | 47.5% | 64.4% | ||
| Q3 25 | 48.4% | 66.4% | ||
| Q2 25 | 52.6% | — | ||
| Q1 25 | 53.6% | — | ||
| Q4 24 | 54.6% | 72.2% | ||
| Q3 24 | 54.5% | 39.6% | ||
| Q2 24 | 55.7% | — | ||
| Q1 24 | 57.1% | — |
| Q4 25 | 1.4% | -63.0% | ||
| Q3 25 | 0.1% | -31.8% | ||
| Q2 25 | -42.6% | — | ||
| Q1 25 | 6.1% | — | ||
| Q4 24 | -233.0% | 14.9% | ||
| Q3 24 | 7.0% | -89.2% | ||
| Q2 24 | 3.7% | — | ||
| Q1 24 | 2.4% | 11.1% |
| Q4 25 | -0.7% | -84.1% | ||
| Q3 25 | -0.8% | 160.1% | ||
| Q2 25 | -43.9% | — | ||
| Q1 25 | 3.9% | — | ||
| Q4 24 | -221.2% | -18.8% | ||
| Q3 24 | 2.5% | -98.0% | ||
| Q2 24 | 1.0% | — | ||
| Q1 24 | -0.5% | 15.9% |
| Q4 25 | $-0.02 | $-0.52 | ||
| Q3 25 | $-0.03 | $1.08 | ||
| Q2 25 | $-1.66 | — | ||
| Q1 25 | $0.14 | — | ||
| Q4 24 | $-8.64 | $-0.10 | ||
| Q3 24 | $0.09 | $-0.27 | ||
| Q2 24 | $0.04 | — | ||
| Q1 24 | $-0.02 | $0.00 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $89.8M | $3.3B |
| Total DebtLower is stronger | $90.3M | — |
| Stockholders' EquityBook value | $778.2M | $2.5B |
| Total Assets | $1.1B | $7.0B |
| Debt / EquityLower = less leverage | 0.12× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $89.8M | $3.3B | ||
| Q3 25 | $70.5M | $1.0B | ||
| Q2 25 | $90.3M | — | ||
| Q1 25 | $97.0M | — | ||
| Q4 24 | $107.7M | $427.3M | ||
| Q3 24 | $89.0M | $98.6M | ||
| Q2 24 | $92.2M | — | ||
| Q1 24 | $75.8M | $259.7M |
| Q4 25 | $90.3M | — | ||
| Q3 25 | $93.4M | — | ||
| Q2 25 | $95.7M | — | ||
| Q1 25 | $98.0M | — | ||
| Q4 24 | $125.3M | — | ||
| Q3 24 | $152.6M | — | ||
| Q2 24 | $164.9M | — | ||
| Q1 24 | $167.2M | — |
| Q4 25 | $778.2M | $2.5B | ||
| Q3 25 | $778.0M | $2.9B | ||
| Q2 25 | $776.3M | — | ||
| Q1 25 | $839.4M | — | ||
| Q4 24 | $828.5M | $1.2B | ||
| Q3 24 | $1.2B | $1.1B | ||
| Q2 24 | $1.2B | — | ||
| Q1 24 | $1.2B | $677.2M |
| Q4 25 | $1.1B | $7.0B | ||
| Q3 25 | $1.1B | $4.3B | ||
| Q2 25 | $1.0B | — | ||
| Q1 25 | $1.1B | — | ||
| Q4 24 | $1.2B | $1.9B | ||
| Q3 24 | $1.7B | $1.3B | ||
| Q2 24 | $1.7B | — | ||
| Q1 24 | $1.7B | $723.6M |
| Q4 25 | 0.12× | — | ||
| Q3 25 | 0.12× | — | ||
| Q2 25 | 0.12× | — | ||
| Q1 25 | 0.12× | — | ||
| Q4 24 | 0.15× | — | ||
| Q3 24 | 0.12× | — | ||
| Q2 24 | 0.13× | — | ||
| Q1 24 | 0.14× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.2M | $71.7M |
| Free Cash FlowOCF − Capex | $21.3M | $-468.0M |
| FCF MarginFCF / Revenue | 11.8% | -253.4% |
| Capex IntensityCapex / Revenue | 3.8% | 292.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $43.1M | $-701.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.2M | $71.7M | ||
| Q3 25 | $14.0M | $142.4M | ||
| Q2 25 | $6.8M | — | ||
| Q1 25 | $25.7M | — | ||
| Q4 24 | $57.9M | $53.6M | ||
| Q3 24 | $23.0M | $-3.9M | ||
| Q2 24 | $27.8M | — | ||
| Q1 24 | $-8.0M | $-27.1M |
| Q4 25 | $21.3M | $-468.0M | ||
| Q3 25 | $7.0M | $-38.0M | ||
| Q2 25 | $-4.2M | — | ||
| Q1 25 | $19.0M | — | ||
| Q4 24 | $53.1M | $-85.5M | ||
| Q3 24 | $20.0M | $-109.7M | ||
| Q2 24 | $21.9M | — | ||
| Q1 24 | $-12.1M | $-108.3M |
| Q4 25 | 11.8% | -253.4% | ||
| Q3 25 | 3.9% | -15.8% | ||
| Q2 25 | -2.4% | — | ||
| Q1 25 | 11.3% | — | ||
| Q4 24 | 29.6% | -73.6% | ||
| Q3 24 | 11.7% | -208.0% | ||
| Q2 24 | 12.8% | — | ||
| Q1 24 | -7.3% | -199.4% |
| Q4 25 | 3.8% | 292.2% | ||
| Q3 25 | 3.9% | 75.0% | ||
| Q2 25 | 6.3% | — | ||
| Q1 25 | 4.0% | — | ||
| Q4 24 | 2.7% | 119.7% | ||
| Q3 24 | 1.8% | 200.6% | ||
| Q2 24 | 3.4% | — | ||
| Q1 24 | 2.5% | 149.5% |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.37× | ||
| Q2 25 | — | — | ||
| Q1 25 | 3.89× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 5.35× | — | ||
| Q2 24 | 15.44× | — | ||
| Q1 24 | — | -3.13× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AVNS
| Enteral Feeding | $83.0M | 46% |
| Radiofrequency Ablation | $36.9M | 20% |
| Neonate Solutions | $32.1M | 18% |
| Surgical Pain And Recovery | $24.7M | 14% |
| Corporate Other | $4.2M | 2% |
IREN
| Bitcoin Mining Revenue | $167.4M | 91% |
| AI Cloud Services | $17.3M | 9% |
